Kunming Chuan Jin Nuo Chemical (300505.SZ) has released a profit forecast, expecting a net profit of 150 million to 185 million yuan in 2024, turning from a loss to a profit year-on-year.
Chuanjinnuo (300505.SZ) released its 2024 performance forecast, expecting that its net profit attributable to shareholders of listed companies for the 2024 fiscal year...
Kunming Chuan Jin Nuo Chemical (300505.SZ) released its performance forecast for the year 2024, expecting a net profit attributable to shareholders of the listed company of 150 million to 185 million yuan, turning losses into profits compared to the previous year.
In 2023, due to market conditions, the company faced losses as it cleared its inventory. In 2024, with the recovery of the phosphate chemical market and the company's flexible advantage in adjusting its product structure according to market conditions, combined with careful production organization, the company's comprehensive gross profit margin increased, significantly improving its profitability.
Related Articles

Triple the dose, with a monthly increase of only $50: Novo Nordisk A/S Sponsored ADR Class B (NVO.US) boosts the dose of Wegovy to compete with Eli Lilly and Company's Zepbound (LLY.US).

Nasdaq ETF changes! BlackRock, Inc. (BLK.US) and State Street (STT.US) are squeezing, and Invesco's (IVZ.US) near 20-year monopolistic position is in jeopardy.

Shareholder of Dosilicon Co., Ltd. (688110.SH) intends to inquire about transferring 1% of the company's shares.
Triple the dose, with a monthly increase of only $50: Novo Nordisk A/S Sponsored ADR Class B (NVO.US) boosts the dose of Wegovy to compete with Eli Lilly and Company's Zepbound (LLY.US).

Nasdaq ETF changes! BlackRock, Inc. (BLK.US) and State Street (STT.US) are squeezing, and Invesco's (IVZ.US) near 20-year monopolistic position is in jeopardy.

Shareholder of Dosilicon Co., Ltd. (688110.SH) intends to inquire about transferring 1% of the company's shares.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


